FENNEC ANNOUNCES RESULTS OF ANNUAL MEETING

May 28, 2015

Research Triangle Park, NC — (Marketwired) – May 28, 2015 – Fennec Pharmaceuticals Inc. (TSX: FRX, OTCQB: FENCF) today announced that the nominees listed in the management proxy circular dated April 23, 2015 (the “Circular”) for the Annual Meeting of Shareholders were elected as directors of the Company at the Annual Meeting of Shareholders held in Durham, North Carolina on May 28, 2015 (the “Meeting”).  Detailed results of the vote for the election of directors are set out below:


Name of Nominee


Votes For


% Votes For


Votes Withheld


% Votes Withheld
Dr. Khalid Islam 5,811,119 99.96% 2,467   0.04%
Mr. Adrian Haigh 5,067,580 87.17 % 746,006 12.83%
Mr. Chris A. Rallis 5,067,580 87.17 % 746,006 12.83%
Mr. Rostislav Raykov 5,067,242 87.16% 746,344 12.84%
Mr. Steven D. Skolsky 5,067,572 87.17% 746,014 12.83%

For further information, please contact:

Rosty Raykov
Chief Executive Officer
Fennec Pharmaceuticals Inc.
T: (919) 636-5144